Anti-FAP CAR T cells produced in vivo reduce fibrosis and restore liver homeostasis in metabolic dysfunction–associated steatohepatitisChittampalli N. Yashaswini, Tran To, Thomas Williamson et al.|Science Translational Medicine|2026Cited by 14
In vivo anti-FAP CAR T therapy reduces fibrosis and restores liver homeostasis in metabolic dysfunction-associated steatohepatitisChittampalli N. Yashaswini, Scott L. Friedman, Bruno Cogliati et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 12